A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for very ill patients who also have multiple myeloma and other blood cancers. The report also suggests that blood cancer patients may have atypical COVID-19 symptoms.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/04/200403124931.htm
No comments:
Post a Comment